ARCHIVES

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

“Mind Boggling” Results Reported In Trials Using 3-Drug Combination For Breast Cancer

October 10, 1975

DCBD Okays Concept For Molecular Probes In Colon Cancer, Two Other Organ Systems Generated Projects

July 4, 1986

FDA Approves SNDA For Gardasil For Anal Cancer And Precancerous Lesions

January 28, 2011

In Brief: Gritz Heads New Dept. At M.D. Anderson; NCI Grants Manager Leo Buscher honored

July 16, 1993

Pittsburgh Broadens Inquiry To Include Lawrence Wickerham

July 15, 1994

List of FY97 SPORE Grantees and Their Awards

December 12, 1997